Pulse Biosciences (PLSE) Stock Price, Quote, News & History | Benzinga

SPY764.10+0.02%QQQ703.11−0.19%BTC/USD81,439.70+0.17%DIA528.58+0.13%GLD368.74−0.07%TLT81.82+0.10%

Pulse Biosciences Inc (PLSE) Stock Price, Quote, News & History

PLSENASDAQ

Trade with Public

Trade with Public

$52.68

1.372.67%

Last update: Oct 22, 4:34 PM

$52.68

1.372.67%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$50.92

Close

$52.68

Volume / Avg.

421.42K / 515.05K

Day Range

$50.00 - $53.67

52 Wk Range

12.56 - 58.90

Market Cap

$3.76B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

55

Short Interest

15.53%

Days to Cover

5.61

Recent Pulse Biosciences Inc News

TriSalus Life Sciences, Lakefront Biotherapeutics, Editas Medicine And Other Big Stocks Moving Higher On Wednesday

U.S. stocks fell as Nasdaq dropped 100+ points, while TriSalus surged 5.8% on FDA clearance; Securitize, Lakefront and others also gained.

Avi Kapoor

This HCA Healthcare Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Analysts initiated bullish coverage on HCA, GRDN, TTC, MRVL and PLSE, setting price targets of $495, $52, $120, $270 and $70.

Avi Kapoor

Wealthfront, Orchestra Biomed, AeroVironment And Other Big Stocks Moving Higher On Thursday

U.S. stocks fell, but Wealthfront surged 6.6% after beating Q2 earnings and revenue estimates; Orchestra Biomed, Clover Health and AeroVironment also rose.

Avi Kapoor

Top 3 Health Care Stocks That May Keep You Up At Night In Q3

As of Aug. 27, 2026, three health care stocks are overbought and could be giving a real warning to momentum investors, according to the RSI indicator.

Avi Kapoor

This Okta Analyst Turns Bullish; Here Are Top 3 Upgrades For Monday

Top Wall Street analysts changed their outlook on top stocks. See analyst ratings and price targets for PMT, ALAB.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-61.10M

Investing Cash Flow (TTM)

-290.00K

Financing Cash Flow (TTM)

56.66M

Free Cash Flow (TTM)

-61.39M

Capital Expenditure (TTM)

-290.00K

Net Change in Cash (TTM)

-4.73M

Analyst Trends and Forecast

1

Jun

2

Aug

2

Sep

2

Oct

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$3.56B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

2948.49

PB Ratio (TTM)

36.78

Earnings Yield % (TTM)

-2.28%

Earnings Yield % (FWD)

-2.60%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$1.40

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$101.62M

Debt to Equity

0.07

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-